Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
about
Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic OpportunitiesMutation analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese patients with myeloproliferative neoplasms.Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells.Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.Lipidomic approach for stratification of acute myeloid leukemia patients.Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemiaThe chemistry of isoindole natural products.Acute Myeloid Leukemia: Advancements in Diagnosis and Treatment.Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluationProfile of pacritinib and its potential in the treatment of hematologic disorders.Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.Cancer epigenetics: new therapies and new challenges.Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Formulation of Genetic Counseling Format for Adult Bangladeshi Patients with Acute Myeloid Leukemia.
P2860
Q26863756-B62270F2-B8B7-4ABC-86D5-961FFFF9163AQ33667448-2873E4C8-DCDC-4465-8272-E5F45AF59B8FQ35016583-A8466138-BFDD-4BA7-8625-B6829F09E4A7Q36038920-762318C5-6129-46B5-93FB-CFE982250409Q36282427-70A4A4A4-ADD1-48FC-B79C-03E7C3532DBDQ37123272-6289E1C2-5A97-40DF-B6D3-9829C8218E20Q37279822-E714A720-3ECB-4A33-A455-E338A4904FC9Q37615574-F413E4DD-7177-433D-8262-89D4FD9445D6Q37699220-12F4ED86-0445-4AC8-A77E-D2A5113C7E3DQ38244524-BA002964-E690-453A-8BC6-58733FCEF85AQ40804607-5BE46C21-B351-4CFE-A0C9-1A772DFCF610Q41379688-E6C25C1B-0F88-4A81-B39B-8F5FF9118793Q43226742-8282886E-9A26-4618-B701-4ED85FB05756Q47135060-FE4BB6B1-4225-4B29-BFF2-CA8DE32A8C94Q55176600-7FC28C48-7BCB-4130-B9CF-34919265569A
P2860
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@ast
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@en
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@nl
type
label
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@ast
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@en
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@nl
prefLabel
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@ast
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@en
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
@nl
P2093
P2860
P1476
Gene mutations and molecularly targeted therapies in acute myeloid leukemia
@en
P2093
Eleftheria Hatzimichael
Evangelos Briasoulis
Georgios Georgiou
Leonidas Benetatos
P2860
P577
2013-01-17T00:00:00Z